Exploring the effect of vitamin D3 supplementation on surrogate biomarkers of cholesterol absorption and endogenous synthesis in patients with type 2 diabetes-randomized controlled trial.

Plain-language guide to PMID 32559272 (2020): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID: 32559272
Journal: The American journal of clinical nutrition
Year: 2020
Study type: Randomized Controlled Trial
Authors: Meng H et al. (5 authors)
DOI: 10.1093/ajcn/nqaa149
Registered trial: NCT01736865

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Inverse associations have been reported between serum 25-hydroxyvitamin D [25(OH)D] and circulating cholesterol concentrations in observational studies.

Who Took Part

The age groups tagged for this paper are middle-aged adults and older adults, both men and women.

Of participants without changes in cholesterol-lowering medications (n = 114), plasma surrogate cholesterol absorption and endogenous synthesis biomarker concentrations were measured and merged with available measures of serum LDL cholesterol and HDL cholesterol concentrations.

How the Study Was Run

The researchers set it up as a randomized and placebo-controlled study.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

Ancillary study of The Vitamin D for Established Type 2 Diabetes (DDM2) trial.

What Was Measured

The subject headings attached to it are Biomarkers, Calcium-Regulating Hormones and Agents, Cholecalciferol, Cholesterol, Diabetes Mellitus, Type 2 and Dietary Supplements.

Author keywords: HDL cholesterol, LDL cholesterol, absorption, biological availability, cholesterol/biosynthesis and cholesterol/metabolism.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 7 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2020 (The American journal of clinical nutrition), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Vitamin D, K2, Magnesium and Zinc in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.